Skip to main content
Kieren Mather, MD, Endocrinology, Indianapolis, IN, Select Specialty Hospital of INpolis

KierenMatherMDFRCPC

Endocrinology Indianapolis, IN

Diabetes, Lipid Metabolism

Professor of Medicine

Dr. Mather is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Mather's full profile

Already have an account?

Education & Training

  • University of Calgary Faculty of Medicine
    University of Calgary Faculty of MedicineClass of 1992

Certifications & Licensure

  • IN State Medical License
    IN State Medical License 1999 - 2023
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Genetic Ancestry Markers and Difference in A1c Between African-American and White in the Diabetes Prevention Program  
    Steven Kahn, William C Knowler, Kieren J Mather, Jose C Florez, The Journal of Clinical Endocrinology and Metabolism
  • Combination GLP-1 and Insulin Treatment Fails to Alter Myocardial Fuel Selection Versus Insulin Alone in Type 2 Diabetes  
    Kieren J Mather, Mark A Green, The Journal of Clinical Endocrinology and Metabolism

Press Mentions

  • Beta-Cell-Targeted Tx Disappoints in New T2D Patients
    Beta-Cell-Targeted Tx Disappoints in New T2D PatientsJune 9th, 2019
  • Type 2 Diabetes Medications Don’t Prevent the Disease in People with Prediabetes, Study Suggests
    Type 2 Diabetes Medications Don’t Prevent the Disease in People with Prediabetes, Study SuggestsJune 11th, 2019
  • Long-Term Follow-up of Diabetes Prevention Program Shows Continued Reduction in Diabetes Development
    Long-Term Follow-up of Diabetes Prevention Program Shows Continued Reduction in Diabetes DevelopmentJune 16th, 2014
  • Join now to see all

Grant Support

  • Preservation Of Beta Cell Function In Prediabetes/Early Type 2 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2011
  • Preservation Of Beta Cell Function In Prediabetes Early Type 2 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2011
  • Modulation Of Human Myocardial Metabolism By GLP-1National Heart, Lung, And Blood Institute2010–2011
  • Repaglinide As A Viable Alternative To Pre-Meal Insulin In Cystic Fibrosis RENational Center For Research Resources2007–2008
  • Myocardial Substrate Selection And Switching In Lean And Obese HumansNational Center For Research Resources2007–2008
  • Dual Actions Of Insulin In The Regulation Of Endothelin Activity In Vivo In HNational Center For Research Resources2006–2008
  • Treating The Endothelium To Restore Insulin SensitivityNational Center For Research Resources2005–2008
  • Mechanism Of Hemodynamically Induced Glucose UptakeNational Center For Research Resources2004–2008
  • PET Approach To Measuring Human Myocardial MetabolismNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
  • The Effects Of Olmesartan Medoxomil, Losartan Potassium, And Atenolol On InsuNational Center For Research Resources2005–2006
  • Role Of Hemodynamics In In Vivo Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases2003

Hospital Affiliations